These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
527 related items for PubMed ID: 1379072
1. Induced peptide conformations in different antibody complexes: molecular modeling of the three-dimensional structure of peptide-antibody complexes using NMR-derived distance restraints. Scherf T, Hiller R, Naider F, Levitt M, Anglister J. Biochemistry; 1992 Aug 04; 31(30):6884-97. PubMed ID: 1379072 [Abstract] [Full Text] [Related]
2. NMR-derived model for a peptide-antibody complex. Zilber B, Scherf T, Levitt M, Anglister J. Biochemistry; 1990 Oct 30; 29(43):10032-41. PubMed ID: 2271636 [Abstract] [Full Text] [Related]
3. NMR study of the complexes between a synthetic peptide derived from the B subunit of cholera toxin and three monoclonal antibodies against it. Anglister J, Jacob C, Assulin O, Ast G, Pinker R, Arnon R. Biochemistry; 1988 Jan 26; 27(2):717-24. PubMed ID: 2450576 [Abstract] [Full Text] [Related]
4. Antibodies against a peptide of cholera toxin differing in cross-reactivity with the toxin differ in their specific interactions with the peptide as observed by 1H NMR spectroscopy. Anglister J, Zilber B. Biochemistry; 1990 Jan 30; 29(4):921-8. PubMed ID: 1692737 [Abstract] [Full Text] [Related]
5. Probing antibody diversity by 2D NMR: comparison of amino acid sequences, predicted structures, and observed antibody-antigen interactions in complexes of two antipeptide antibodies. Levy R, Assulin O, Scherf T, Levitt M, Anglister J. Biochemistry; 1989 Sep 05; 28(18):7168-75. PubMed ID: 2819059 [Abstract] [Full Text] [Related]
6. Crystal structure of an anticholera toxin peptide complex at 2.3 A. Shoham M. J Mol Biol; 1993 Aug 20; 232(4):1169-75. PubMed ID: 7690406 [Abstract] [Full Text] [Related]
7. NMR observation of interactions in the combining site region of an antibody using a spin-labeled peptide antigen and NOESY difference spectroscopy. Scherf T, Hiller R, Anglister J. FASEB J; 1995 Jan 20; 9(1):120-6. PubMed ID: 7821751 [Abstract] [Full Text] [Related]
8. Structure of an anti-cholera toxin antibody Fab in complex with an epitope-derived D-peptide: a case of polyspecific recognition. Scheerer P, Kramer A, Otte L, Seifert M, Wessner H, Scholz C, Krauss N, Schneider-Mergener J, Höhne W. J Mol Recognit; 2007 Jan 20; 20(4):263-74. PubMed ID: 17712773 [Abstract] [Full Text] [Related]
9. Structural diversity in a conserved cholera toxin epitope involved in ganglioside binding. Shoham M, Scherf T, Anglister J, Levitt M, Merritt EA, Hol WG. Protein Sci; 1995 May 20; 4(5):841-8. PubMed ID: 7545048 [Abstract] [Full Text] [Related]
10. Two-dimensional NMR investigations of the interactions of antibodies with peptide antigens. Anglister J, Scherf T, Zilber B, Levy R, Zvi A, Hiller R, Feigelson D. FASEB J; 1993 Sep 20; 7(12):1154-62. PubMed ID: 8375614 [Abstract] [Full Text] [Related]
11. Two-dimensional NMR studies of the interactions between a peptide of cholera toxin and monoclonal antibodies. Anglister J, Scherf T, Zilber B, Levy R. Biopolymers; 1995 Sep 20; 37(6):383-9. PubMed ID: 8589243 [Abstract] [Full Text] [Related]
12. Molecular basis for the binding polyspecificity of an anti-cholera toxin peptide 3 monoclonal antibody. Otte L, Knaute T, Schneider-Mergener J, Kramer A. J Mol Recognit; 2006 Sep 20; 19(1):49-59. PubMed ID: 16273596 [Abstract] [Full Text] [Related]
13. Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy. Zvi A, Feigelson DJ, Hayek Y, Anglister J. Biochemistry; 1997 Jul 15; 36(28):8619-27. PubMed ID: 9214308 [Abstract] [Full Text] [Related]
14. Structure, function and properties of antibody binding sites. Mian IS, Bradwell AR, Olson AJ. J Mol Biol; 1991 Jan 05; 217(1):133-51. PubMed ID: 1988675 [Abstract] [Full Text] [Related]
15. Crystal parameters and molecular replacement of an anticholera toxin peptide complex. Shoham M, Proctor P, Hughes D, Baldwin ET. Proteins; 1991 Jan 05; 11(3):218-22. PubMed ID: 1749774 [Abstract] [Full Text] [Related]
16. Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,). Li Y, Li H, Smith-Gill SJ, Mariuzza RA. Biochemistry; 2000 May 30; 39(21):6296-309. PubMed ID: 10828942 [Abstract] [Full Text] [Related]
17. Interactions of antibody aromatic residues with a peptide of cholera toxin observed by two-dimensional transferred nuclear Overhauser effect difference spectroscopy. Anglister J, Levy R, Scherf T. Biochemistry; 1989 Apr 18; 28(8):3360-5. PubMed ID: 2742841 [Abstract] [Full Text] [Related]
18. Tyrosine plays a dominant functional role in the paratope of a synthetic antibody derived from a four amino acid code. Fellouse FA, Barthelemy PA, Kelley RF, Sidhu SS. J Mol Biol; 2006 Mar 17; 357(1):100-14. PubMed ID: 16413576 [Abstract] [Full Text] [Related]
19. Detailed analysis of the free and bound conformations of an antibody. X-ray structures of Fab 17/9 and three different Fab-peptide complexes. Schulze-Gahmen U, Rini JM, Wilson IA. J Mol Biol; 1993 Dec 20; 234(4):1098-118. PubMed ID: 8263915 [Abstract] [Full Text] [Related]
20. Mutual conformational adaptations in antigen and antibody upon complex formation between an Fab and HIV-1 capsid protein p24. Monaco-Malbet S, Berthet-Colominas C, Novelli A, Battaï N, Piga N, Cheynet V, Mallet F, Cusack S. Structure; 2000 Oct 15; 8(10):1069-77. PubMed ID: 11080628 [Abstract] [Full Text] [Related] Page: [Next] [New Search]